FREE PREMIUM SUBSCRIPTION FOR 14 DAYS!
Which way will ALDX go? Request
Key Stats
Beta 1.04
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 80 ] RSI14 is 27 and the stock is currently not being overbought or oversold

Red day on Friday for Aldeyra Therapeutics (Updated on July 30, 2021)


Sell candidate since 2021-07-01 Loss -21.31%

The Aldeyra Therapeutics stock price fell by -1.33% on the last day (Friday, 30th Jul 2021) from $9.02 to $8.90. and has now fallen 3 days in a row. During the day the stock fluctuated 3.64% from a day low at $8.78 to a day high of $9.10. The price has fallen in 6 of the last 10 days and is down by -6.51% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -11 thousand shares and in total, 301 thousand shares were bought and sold for approximately $2.68 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -24.36% during the next 3 months and, with a 90% probability hold a price between $6.36 and $8.23 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, July 26, 2021, and so far it has risen 3.13%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Aldeyra Therapeutics stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $8.97 and $10.55. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 months Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss

Aldeyra Therapeutics finds support from accumulated volume at $8.81 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.32 between high and low, or 3.64%. For the last week, the stock has had a daily average volatility of 5.57%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Aldeyra Therapeutics stock A Buy?

Aldeyra Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.017

Predicted Opening Price for Aldeyra Therapeutics of Monday, August 2, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price August 2, 2021 Current price
$8.93 $8.90 (Undervalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On April 28, 2021 "Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell" gave "" rating for ALDX. The price target was changed from $22.00 to $25.00.

Volatility
5.57 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $9.19
Price: $8.90
Support: $8.81

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 9.25 3.90 %
9.12 2.52 %
9.05 1.67 %
Current price: 8.90
Support 8.80 -1.07 %
8.73 -1.92 %
8.61 -3.30 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 10.07 13.15 %
9.27 4.16 %
9.19 3.26 %
Current price 8.90
Support 8.81 -1.01%
8.63 -3.03%
0 .

Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, focuses on the development of products for diseases caused by inflammation and inborn errors of metabolism in the United States and internationally. It is developing NS2, a small molecule designed to trap and allow for the degradation of aldehydes. Its product is used for the treatment of allergic conjunctivitis, noninfectious anterior uveitis, sjögren-larsson syndrome, and succinic semi-aldeh... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT